OpenBench - Crunchbase Company Profile & Funding

Overview

OpenBench

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About OpenBench

CB Rank

296645

Success-Driven Molecular Discovery

Founded

obfuscation

Private

San Francisco, California, United States

1-10

openbench.com

Biopharma

Biotechnology

Information Technology

Life Science

Key People

Jim Thompson: Founder & COO
James Yoder: Founder & CEO

Details

Legal Name

OpenBench, Inc.

Operating Status

Active

Company Type

For Profit

Founders

James Yoder, Jim Thompson

About the Company

OpenBench is pioneering a success-driven standard in early small molecule discovery. We bear the cost and scientific risk of screening so that the first dollar our partners spend is to purchase potent, novel, and developable chemical matter. OpenBench-discovered molecules fuel the pipelines of many of the world’s most innovative therapeutics

companies. OpenBench's structure-based artificial intelligence has designed and confirmed the most potent known chemical matter for 11 target binding sites, discovering agonists, competitive and allosteric inhibitors, and potent non-functional binders for use in proximity-inducing modalities.

Contact Email

discovery@openbench.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Success-Driven Molecular Discovery Service

A fee-for-success small molecule hit discovery service that screens trillions of compounds and charges clients only for hit series that meet predefined success criteria.

Structure-Based Virtual Screening Platform

An AI-enabled platform that performs structure-based virtual screening of multi-trillion compound libraries to identify novel, potent chemical series for drug discovery.